✦ LIBER ✦

Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis

✍ Scribed by C. Collin; P. Davies; I. K. Mutiboko; S. Ratcliffe; for the Sativex Spasticity in MS Study Group

Book ID: 111064953
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 528 KB
Volume: 14
Category: Article
ISSN: 1351-5101
DOI: 10.1111/j.1468-1331.2006.01639.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, controlled trial of dextrome

Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis

✍ Hillel S. Panitch; Ronald A. Thisted; Richard A. Smith; Daniel R. Wynn; James P. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB 👁 2 views

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis

✍ A. Novotna; J. Mares; S. Ratcliffe; I. Novakova; M. Vachova; O. Zapletalova; C. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB

Biased assessment of blinding in a rando

Biased assessment of blinding in a randomized placebo-controlled trial of oral methotrexate in chronic progressive multiple sclerosis

✍ D. W. J. Dippel; P. G. Oomes; L. H. Visser 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

Randomized placebo-controlled trial of m

Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome

✍ E. Millefiorini; C. Gasperini; C. Pozzilli; F. D’Andrea; S. Bastianello; M. Troj 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 44 KB

The effect of cannabis on urge incontine

The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS)

✍ R. M. Freeman; O. Adekanmi; M. R. Waterfield; A. E. Waterfield; D. Wright; J. Za 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 292 KB

Rituximab in patients with primary progr

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial

✍ Kathleen Hawker; Paul O'Connor; Mark S. Freedman; Peter A. Calabresi; Jack Antel 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 2 views

## Abstract ## Objective Rituximab, a monoclonal antibody selectively depleting CD20+ B cells, has demonstrated efficacy in reducing disease activity in relapsing‐remitting multiple sclerosis (MS). We evaluated rituximab in adults with primary progressive MS (PPMS) through 96 weeks and safety thro